MAPK8 and prostate cancer: Moreover, Kwon et al. [56] reported that chemical inhibition of JNK in DU145 prostate cancer cells reduces both cell migration and vascular-endothelial growth factor (VEGF) expression, a proangiogenic factor that may facilitate tumor growth and metastasis.